LexDanaLexDanabeta
Inventor

XIAO-CHI JIA

Inventor
US

Overview

3→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides21%
G01NInvestigating or analysing materials by determining their chemical or physical properties14%
B82YSpecific uses or applications of nanostructures7%
C07HSugars7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
PatentTitleYear
11,634,503Antibody drug conjugates (ADC) that bind to 158P1D7 proteins202311,492,411Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof202211,401,347Antibodies and molecules derived therefrom that bind to STEAP-1 proteins2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2023Patents assigned to AGENSYS INC (2)· patent assignee history
2022Patents assigned to AMGEN FREMONT INC (1)· patent assignee history
2022–2023Based in US· patent location history
2023Patents assigned to SEAGEN INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AGENSYS INC22022–2023
AMGEN FREMONT INC12022
SEAGEN INC12023
Locations
LocationPatentsSpan
US32022–2023